Device for Age-related Macular Degeneration (AMD)

Completed

Conditions studied: Age-Related Macular Degeneration

In brief

This study involves user acceptability and feedback of KalEYEdoscope, a digital, handheld device utilizing shape-discrimination hyperacuity to distinguish the severity of age-related macular degeneration (AMD).

Key facts

Study ID

NCT06178978

Run by

University of Michigan

People needed

31

Starts

2022-03-10

Expected to finish

2022-03-25

Last updated by the study team

2023-12-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any patient aged 18 years or older with age-related macular degeneration who is seen at the Kellogg Eye Center.

You may not qualify if…

• pregnant women, prisoners, severe cognitive impairment, and diagnoses (mental or neuromuscular disorders) which could preclude independent use of the device.

Where it is running

• University of Michigan Kellogg Eye Center — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.